SEO-ABM

Significance of the project

Contribution to improving public health

he principal anticipated outcome of the project is improved public health. The innovative eye drops under development, based on self-emulsifying ophthalmic systems (SEO), will enable effective administration of medicines that are unstable in aqueous environments, including antibiotics. This may make it possible to treat ophthalmic conditions for which convenient and effective treatment options are currently lacking.

 

SEO technology provides stability of the active substances, patient comfort and the potential for prolonged drug action on the ocular surface, thereby improving treatment effectiveness and reducing the need for frequent administration. Such solutions may contribute not only to better vision and ocular health but also, indirectly, to society’s adaptation to challenges associated with population ageing and climate change.

 

 

Economic impact

Pharmaceutical companies in Poland are reluctant to invest in new solutions, even when the investments involved are relatively modest. For this reason, the project includes a stage that is generally absent from academic projects: preparation of product registration documentation. This will enable potential investors, including those with limited experience, to assess more accurately the additional expenditure required to introduce the product into manufacture. This stage will also familiarise the researchers with the specific regulatory and implementation requirements for medicinal products, strengthening the University’s capacity to cooperate with industry.

The Medical University of Gdańsk is the lead institution in 15 research projects funded by the Medical Research Agency (ABM), with a combined value exceeding PLN 191 million. As links between scientific activity and the commercial application of research findings have developed, the Technology Transfer Centre (CTT) was established. Its principal purpose is to support the transfer of knowledge and scientific achievements and promote their commercialisation among businesses. The high quality of this support is demonstrated by funding secured from the Ministry of Science and Higher Education (MNiSW) for the Innovation Incubator+ project and by cooperation with EIT Health in implementing EIT Health InnoStars Activities. Through its participation in the EIT Health InnoStars programme, MUG has become an incubator for entrepreneurship in the medical, health and life sciences in northern Poland.